BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Legend Biotech Appoints Carlos Santos as Chief Financial Officer

  August 19, 2025

   · 

  5 min read
• Press Releases

  Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business Update

  August 19, 2025

   · 

  9 min read
• Press Releases

  Opus Genetics Announces FDA Clearance of IND Application for Gene Therapy Candidate OPGx-BEST1

  August 19, 2025

   · 

  4 min read
• Press Releases

  NewAmsterdam Announces Acceptance of Marketing Authorization Applications for Review by European Medicine Agency for Obicetrapib

  August 19, 2025

   · 

  12 min read
• Press Releases

  Ultragenyx Initiates Rolling Submission of Biologics License Application (BLA) to U.S. FDA for DTX401 AAV Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)

  August 19, 2025

   · 

  6 min read
• Press Releases

  Catheter Precision Receives Approval for LockeT in the United Kingdom

  August 19, 2025

   · 

  3 min read
• Press Releases

  OncoC4 Strengthens Leadership Team with Appointment of Shiniu Wei as Chief Financial Officer

  August 19, 2025

   · 

  3 min read
• Press Releases

  A Drug that Could Reduce Metastatic Cancer Resurgence due to Its Anti-Inflammatory Effects in Viral Infections is in Clinical Trials

  August 19, 2025

   · 

  8 min read
• Press Releases

  Aspire Biopharma Announces Positive Top-Line Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)

  August 19, 2025

   · 

  8 min read
• Press Releases

  Skyhawk Therapeutics Announces Strategic Collaboration with Merck KGaA, Darmstadt, Germany to Discover Novel RNA-Targeting Small Molecules for Neurological Disorders

  August 19, 2025

   · 

  3 min read